Fundraising Fox

Rezo Therapeutics

San Francisco, US · Founded 2021 · Delaware corporation · 6 known investors

rezotx.com ↗

Rezo Therapeutics is a drug discovery and development company focused on oncology and inflammation therapeutic areas. The company combines artificial intelligence, chemistry, and high-throughput wet lab experiments to advance small molecule drug candidates from discovery through clinical development.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

NK
Nevan KroganCo-Founder
SB
Sourav BandyopadhyayCo-Founder
NB
Norbert BischofbergerCo-Founder
NJ
Natalia JuraCo-Founder
GS
George ScangosCo-Founder
KS
Kevan ShokatCo-Founder
DH
Derek HicksChief Executive Officer
CG
Cristiana GuiducciChief Scientific Officer
CS
Chris SinzSenior Vice President of Drug Discovery
IG
Ivan GrubisicVice President of Computational Biology and AI
SG
Simeon GeorgeDirector
TA
Tiba AynechiDirector

Investors · 6

Andreessen Horowitz✓ verifiedMenlo Park · $500K – $50Mvia Vineeta Agarwala · board
Norwest Venture Partners✓ verifiedMenlo Park · $10M – $30Mvia Tiba Aynechi · board
HAWKTAILSan Francisco
Valkyrie Ventures Management, LlcPark City
ARCH Venture PartnersreportedChicago · $50K – $250Mvia George Scangos · board
SR One Capital ManagementreportedRedwood City

Reported raises · per SEC filings

Form D private placements
▶$68.1MraisedAug 2025 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Simeon GeorgeDirector
  • Derek HicksExecutive Officer, Director
  • Nevan KroganExecutive Officer, Director
  • Tiba AynechiDirector
  • Jennifer ChangExecutive Officer
  • George ScangosDirector
  • Norbert BischofbergerDirector
  • Vineeta AgarwalaDirector
Offering amount
$80.1M
Amount sold
$68.1M
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news